Rascase 1.5 mg Injection

About Rascase 1.5 mg Injection

Rascase 1.5 mg Injection is an effective treatment designed to manage elevated uric acid levels in the bloodstream, a condition referred to as hyperuricemia. This medication is especially beneficial for patients receiving chemotherapy for specific cancers, including leukemia, lymphoma, and various solid tumors, as well as those at risk of tumor lysis syndrome (TLS), a serious complication that can arise during cancer treatment. Rascase functions by converting uric acid into allantoin, a more soluble substance that the kidneys can easily eliminate, thus preventing potential complications associated with high uric acid levels. It's crucial for patients to be aware of possible side effects, which may include allergic reactions or infusion-related symptoms, and to discuss any pre-existing health conditions with their healthcare provider prior to use. This injection is typically administered under medical supervision to ensure optimal safety and effectiveness. As a key player in cancer care, Rascase not only alleviates the risks of hyperuricemia but also supports overall treatment protocols, enhancing patient outcomes. Always consult with a healthcare professional for tailored advice and monitoring during treatment with Rascase.